Jefferies Adjusts Price Target on Arrowhead Pharmaceuticals to $103 From $100, Maintains Buy Rating
© MT Newswires 2021
| All news about ARROWHEAD PHARMACEUTICALS, INC. |
|
| 05/13 | B. Riley Lowers Arrowhead Pharmaceuticals' PT to $82 from $106 to Account for Higher Re.. | MT |
| 05/12 | TRANSCRIPT : Arrowhead Pharmaceuticals, Inc. Presents at Bank of America 2022 Healthcare C.. | CI |
| 05/12 | NORTH AMERICAN MORNING BRIEFING : Stocks Seen -3- | DJ |
| 05/11 | Piper Sandler Lowers Arrowhead Pharmaceuticals Price Target to $72 From $89, Maintains .. | MT |
| 05/11 | Chardan Lowers Arrowhead Pharmaceuticals Price Target to $80 From $94, Maintains Buy Ra.. | MT |
| 05/11 | Inflation: Have we passed the peak yet? | |
| 05/11 | ANALYST RECOMMENDATIONS : Electronic Arts, Corning, Arrowhead Pharma, Tesla, Wynn Resorts... | |
| 05/11 | Baird Upgrades Arrowhead Pharmaceuticals to Outperform From Neutral, Cuts Price Target .. | MT |
| 05/10 | TRANSCRIPT : Arrowhead Pharmaceuticals, Inc., Q2 2022 Earnings Call, May 10, 2022 | CI |
| 05/10 | ARROWHEAD PHARMACEUTICALS, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL COND.. | AQ |
| |
|
| Analyst Recommendations on ARROWHEAD PHARMACEUTICALS, INC. |
|
| |
|
|
|
| Sales 2022 |
304 M
-
-
|
| Net income 2022 |
-105 M
-
-
|
| Net cash 2022 |
453 M
-
-
|
| P/E ratio 2022 |
-31,4x |
| Yield 2022 |
- |
|
| Capitalization |
3 616 M
3 616 M
-
|
| EV / Sales 2022 |
10,4x |
| EV / Sales 2023 |
12,0x |
| Nbr of Employees |
329 |
| Free-Float |
- |
|
Chart ARROWHEAD PHARMACEUTICALS, INC.
|
Duration :
Period :
|
Technical analysis trends ARROWHEAD PHARMACEUTICALS, INC.
| Short Term | Mid-Term | Long Term | | Trends | Bearish | Bearish | Bearish |
Income Statement Evolution
|
| Mean consensus |
BUY |
| Number of Analysts |
11 |
| Last Close Price |
35,15 $ |
| Average target price |
80,08 $ |
| Spread / Average Target |
128% |
|
English (UK)
English (Canada)
Deutsch (Deutschland)
Deutsch (Schweiz)
Español
Français (France)
Italiano
Nederlands (Nederland)
Nederlands (België)
Report
